###begin article-title 0
Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Mitochondrial dysfunction, oxidative damage and the accumulation of somatic mutations in mitochondrial DNA (mtDNA) have been associated with certain neurodegenerative disorders. Previous studies have also provided controversial results on the association of mtDNA haplogroups with susceptibility to Alzheimer's disease (AD), but possible relationships between mtDNA and frontotemporal lobar degeneration (FTLD) have been less frequently studied.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 109 117 <span type="species:ncbi:9606">Patients</span>
We analysed the role of mtDNA and its maintenance enzymes in 128 early-onset AD (eoAD) and in 66 FTLD cases. Patients and 99 controls were collected from a defined region of Finland, that of Northern Ostrobothnia, for the determination of mtDNA haplogroups and the analysis of two common mtDNA mutations (m.3243A>G, m.8344A>G). In addition, screening was performed for five common POLG1 mutations (T251I, A467T, P587L, W748S and Y955C) and all the coding exons of the PEO1 and ANT1 genes were screened for mutations.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 130 132 130 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
The frequency of haplogroup cluster IWX was 2.3 fold higher among the FTLD cases than in the controls (OR 2.69, 95% CI 1.09-6.65, p = 0.028). The frequency of mtDNA haplogroups or clusters did not differ between the eoAD cases and controls. The two mtDNA mutations and five POLG1 mutations were absent in the eoAD and FTLD patients. No pathogenic mutations were found in the PEO1 or ANT1 genes.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
We conclude that the haplogroup cluster IWX was associated with FTLD in our cohort. Further studies in other ethnically distinct cohorts are needed to clarify the contribution of mtDNA haplogroups to FTLD and AD.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSEN1</italic>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSEN2</italic>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP</italic>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 417 418 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 485 489 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 508 512 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGRN</italic>
###xml 602 603 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 604 605 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) are the two most common neurodegenerative diseases leading to early-onset dementia. Causative mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) and amyloid precursor protein (APP) genes have been found in a few patients with familial AD [1]. The epsilon4 allele of the apolipoprotein E gene (ApoE) has a significant association with AD [2]. Pathogenic mutations in the microtubule-associated protein tau (MAPT) and progranulin (PGRN) genes have rarely been identified in FTLD despite the high frequency of familial cases [3-5]. Most AD and FTLD cases have a complex etiology, however, and many genetic and also behavioural and environmental risk factors may play a role in the disease processes.
###end p 10
###begin p 11
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1</italic>
###xml 572 576 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1</italic>
###xml 629 633 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1</italic>
###xml 872 878 868 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 1022 1023 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1137 1139 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1275 1277 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1278 1280 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1307 1309 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1310 1312 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1564 1566 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1666 1668 1656 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1755 1757 1745 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1758 1760 1748 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1900 1902 1890 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 909 916 <span type="species:ncbi:9606">patient</span>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
###xml 1435 1438 <span type="species:ncbi:9606">Men</span>
###xml 1492 1497 <span type="species:ncbi:9606">women</span>
There is growing evidence to suggest that mitochondria play an important role in ageing and in neurodegenerative diseases. Mitochondrial dysfunction leads to reduced ATP production, increased generation of reactive oxygen species and also impaired calcium buffering [6]. The brain is especially vulnerable to oxidative damage, and mutations in mitochondrial DNA (mtDNA) and in the genes involved in mtDNA maintenance are associated with variable spectrum of mitochondrial disorders affecting the brain [7,8]. POLG1, encoding the catalytic subunit of DNA polymerase gamma, PEO1, coding for the mitochondrial helicase Twinkle, and ANT1, encoding the adenine nucleotide translocator, are important for mtDNA replication. Pathogenic mutations in mtDNA or in its maintenance genes have rarely been described in neurodegenerative diseases leading to dementia. Y955C mutation in POLG1 was previously identified in a patient with progressive external opthalmoplegia (PEO) who had Alzheimer pathology and multiple mtDNA deletions [9], There are also some patients with pathogenic mtDNA mutations suffering from dementia and cognitive impairment [10]. MtDNA polymorphisms and certain haplogroups have been associated with neurodegenerative diseases such as Parkinson's disease and AD [11-13] and also with longevity [14-16]. Previous studies have reached variable conclusions with regard to the association of certain mtDNA haplogroups with AD. Men with haplogroup U had an increased risk of AD, while women with the same haplogroup had a significant decrease in that risk [17]. Furthermore, haplogroups K and U seemed to neutralize the effect of the epsilon4 allele of ApoE [18]. However, in some studies no association was found between mtDNA haplogroups and AD [19-21]. So far there is only one report on frontotemporal dementia and mtDNA haplogroups, reporting no evidence of any association between them [22].
###end p 11
###begin p 12
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 120 128 <span type="species:ncbi:9606">Patients</span>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
We report here on investigations into the role of mtDNA and its maintenance enzymes in AD and FTLD in Finnish patients. Patients and controls were collected from a defined region of Finland, that of Northern Ostrobothnia, for the determination of mtDNA haplogroups and the analysis of two common mtDNA mutations (m.3243A>G, m.8344A>G) in the patients. Since encephalopathy and cognitive decline are common features in mitochondrial diseases, screening was performed for five common POLG1 mutations (T251I, A467T, P587L, W748S and Y955C) and all the coding exons of the PEO1 and ANT1 genes were screened for mutations.
###end p 12
###begin title 13
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 13
###begin title 14
Subjects
###end title 14
###begin p 15
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 29 32 <span type="species:ncbi:9606">men</span>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
###xml 261 269 <span type="species:ncbi:9606">Patients</span>
###xml 573 581 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">patients</span>
We examined 194 patients (92 men) with early-onset AD and FTLD at the Department of Neurology of Oulu University Hospital, Finland. The patients were all from the population of the province of Northern Ostrobothnia and their parents were all of Finnish origin. Patients from other ethnic groups were not able to participate the study. Probable AD had been diagnosed according to the NINCDS-ADRDA criteria [23] in 128 cases and FTLD according to the clinical diagnostic criteria for that disease in 66 cases [24]. The mean age at onset was 58 years (range 38-64) for the AD patients and 58.5 years (range 40-79) for the FTLD patients.
###end p 15
###begin p 16
###xml 167 169 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Use was made of results obtained previously from a mtDNA haplogroup analysis of 99 control subjects (mean age 40 +/- 12 years, range 19-64) from Northern Ostrobotnia [25]. The controls were healthy anonymous blood donors whose mothers had also been free of neurological diseases and the common manifestations of mitochondrial diseases such as hearing impairment and diabetes mellitus. Furthermore, the donors and their mothers were required to be born in the same province, in order to obtain a good representation of the ancestral population of the province.
###end p 16
###begin p 17
Written informed consent was obtained from all the individuals or those caring for them. The research protocols were approved by the Ethics Committees of the Northern Ostrobothnia Hospital District and the Finnish Red Cross.
###end p 17
###begin title 18
Molecular methods
###end title 18
###begin p 19
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Total genomic DNA was extracted from the blood samples by the standard sodium dodecyl sulphate-proteinase K method. Fragments amplified by the polymerase chain reaction (PCR) technique were used for restriction fragment analysis (RFLP), conformation-sensitive gel electrophoresis (CSGE) [26], sequencing and mtDNA haplogroup analysis.
###end p 19
###begin p 20
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI </italic>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BglI </italic>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
The m.3243A>G mutation was screened by RFLP using the restriction enzyme ApaI [27]. The m.8344A>G mutation was detected by RFLP using BglI [28]. MtDNA haplogroups (H, V, U, K, J, T, I, W, X) were determined by RFLP of polymorphic sites as described previously [29,30]. These haplogroups can be grouped into clusters (HV, UK, JT, IWX) according to their phylogenetic background [30].
###end p 20
###begin p 21
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BseNI</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MscI</italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XmaI</italic>
###xml 357 358 357 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 424 425 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 549 556 <span type="species:ncbi:9606">patient</span>
The POLG1 mutations T251I (BseNI), A467T (MscI) and P587L (XmaI) were analysed by RFLP, while the W748S mutation was verified by allele-specific amplification using primers with a locked nucleic acid (LNA) nucleoside base at the 3'end (Proligo LLC, Paris, France). The primers were designed to anneal with either the wild type sequence (5'-GGACATCCCTGGCTGCTG-3') or the sequence containing the mutation (5'-GGACATCCCTGGCTGCTC-3'). Detection of the Y955C mutation was performed by CSGE. The POLG1 exon 18, coding for the Y955, was amplified from the patient samples and from a control sample with a known sequence. The amplified fragments were mixed, denatured at 95degreesC for 5 min and the heteroduplexes were allowed to anneal at 68degreesC for 30 min. The samples were electrophoresed through a polyacrylamide gel overnight at a constant voltage of 400 V, stained in 10 mul/100 ml SYBR Gold solution (Invitrogen, Eugene, Oregon, U.S.A.) for 5 min, visualized with an UV transluminator and photographed (Chemi-Doc XRS, Bio-Rad Laboratories, CA, U.S.A.).
###end p 21
###begin p 22
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
All the coding exons and exon-intron boundaries of PEO1 and ANT1 were screened using CSGE. Fragments were further sequenced if they differed in mobility on the CSGE. Sequencing was carried out using the BigDye Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, U.S.A.) and the ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). The apolipoprotein E genotype was determined as described previously [31].
###end p 22
###begin title 23
Statistical analyses
###end title 23
###begin p 24
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 234 236 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 488 490 486 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
Differences in the frequencies of mtDNA haplogroups and haplogroup clusters between the populations were evaluated using the exact test of population differentiation [32] as implemented in Arlequin 2.0 or, if applicable, using the chi2 test or Fisher's exact test in the SPSS 16.0 software for Windows. The referent group consisted of all cases classified as carriers of other haplogroup or haplogroup cluster than the one under study. The minimum significance level was set at two-sided p = 0.05. The 95% confidence intervals of odds ratio (OR) were calculated. The patients and controls were stratified into two subgroups according to their ApoE genotype: individuals carrying at least one ApoE epsilon4 allele (ApoE4+) and non-ApoE epsilon4 carriers (ApoE4-).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 209 211 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 419 421 419 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 432 434 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 580 582 580 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
MtDNA haplogroups were determined in 128 patients with eoAD and 66 with FTLD and compared with the previous results for the 99 controls (Table 1). The haplogroup frequencies differed between the three groups (p = 0.04; exact test of population differentiation). No significant difference was found in the frequency of haplogroups when patients with eoAD and patients with FTLD were separately compared to the controls (p = 0.41 and p = 0.074, respectively, exact test of population differentiation). However, a difference was found between patients with eoAD and those with FTLD (p = 0.006).
###end p 26
###begin p 27
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Frequencies of mtDNA haplogroups among the eoAD and FTLD patients and the controls.
###end p 27
###begin p 28
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 254 256 254 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 527 529 527 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 461 469 <span type="species:ncbi:9606">patients</span>
Subsequently, we analysed the frequencies of clusters of phylogenetically related haplogroups HV, UK, JT and IWX (Table 2). The frequency of haplogroup cluster IWX was 2.3 fold higher among the FTLD cases than in the controls (OR 2.69, 95% CI 1.09-6.65, p = 0.028). No significant differences were observed in the frequencies of haplogroup clusters HV, UK and JT between the FTLD cases and controls (Table 3). The frequency of haplogroup W was higher among the patients with FTLD than in the controls but not significantly so (p = 0.25).
###end p 28
###begin p 29
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Frequencies of mtDNA haplogroup clusters among the eoAD and FTLD patients and the controls.
###end p 29
###begin p 30
Odds ratios of mtDNA haplogroup clusters by comparison with referent category consisting of all cases classified as carriers of other clusters than the one under study.
###end p 30
###begin p 31
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 327 329 327 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 450 452 450 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 181 188 <span type="species:ncbi:9606">patient</span>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
###xml 414 422 <span type="species:ncbi:9606">patients</span>
###xml 498 506 <span type="species:ncbi:9606">patients</span>
The frequencies of mtDNA haplogroups were not significantly different between the eoAD patients and the controls (Table 1). Haplogroup H was the most common in both the control and patient groups (Table 1). The frequency of haplogroup H was slightly but not significantly higher in the patients with eoAD than in the controls (p = 0.15). The frequency of cluster HV was higher, but not significantly so, in the AD patients than that in the controls (p = 0.23). ApoE4 allele was more frequent in AD patients than in controls (63.3% vs 35.1%, respectively). We found no association between carriers of ApoE4 allele and mtDNA haplogroups.
###end p 31
###begin p 32
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
In addition, we analysed two mtDNA mutations and mutations in three nuclear-encoded enzymes which contribute to mtDNA integrity. The m.3243A>G and m.8344A>G mutations and the five common POLG1 mutations, T251I, A467T, P587L, W748S and Y955C, were absent in this population. Four single nucleotide polymorphisms (SNP) and one single nucleotide insertion were found in the PEO1 and ANT1 genes, but no pathogenic mutations (see additional files 1 and 2). One of the polymorphisms has not been reported previously.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 968 976 <span type="species:ncbi:9606">patients</span>
We found a significant association between haplogroup cluster IWX and FTLD. Within this cluster, frequency of haplogroup W was highest in FTLD patients compared to the controls and eoAD patients. Interestingly, the non-synonymous/synonymous rate in the mtDNA-encoded complex I genes (MTND) is higher within haplogroup cluster IWX than in the remaining European haplogroup clusters [12] thus suggesting that the relative excess of nonsynonymous mutations in cluster IWX may have a role in the risk of developing FTLD. Another possible explanation for the observed association found in our cohort between cluster IWX and FTLD is a recent founder effect. There have been only a few previous reports of associations between the haplogroup W and certain diseases mainly due to its presence at low level in the population making it difficult to detect associations. In one report, however, an association is demonstrated for Iranian Leber hereditary optic neuropathy (LHON) patients with the m.3460G>A mutation, suggesting that W might be a haplotype that increases the penetrance of LHON [33].
###end p 34
###begin p 35
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1265 1266 1265 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 478 483 <span type="species:ncbi:9606">women</span>
###xml 860 868 <span type="species:ncbi:9606">patients</span>
###xml 1009 1017 <span type="species:ncbi:9606">patients</span>
Our study showed no significant differences in the frequencies of mtDNA haplogroups or haplogroup clusters between the eoAD patients and controls. The frequency of HV cluster was higher among the eoAD patients than among the controls, but the difference was not significant. Interestingly, this haplogroup cluster has also been reported to be significantly associated with the risk of late-onset AD independently of ApoE genotype in a Polish population [34]. In the same study, women with haplogroup H were found to have an elevated risk of AD, but the effect was no longer statistically significant after adjustment for age and ApoE genotype. In addition, a weak association has also been observed between haplogroup H and pathologically confirmed dementia with Lewy bodies [19]. In our sample the frequency of haplogroup H was slightly higher among the eoAD patients than among the controls, the relative risk (RR) being 1.28. We calculated the relative risk attached to haplogroup H among the total of 957 patients with AD in four previous association studies and the present study, involving altogether 900 controls, and found it to be 1.2 (range 1.06-1.28), which lends support to a possible role for haplogroup H regarding the risk of AD (see additional file 3).
###end p 35
###begin p 36
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Comparisons of nucleotide diversity and neutrality tests in European haplogroup clusters have shown that there are haplogroup-specific differences in the intensity of selection against particular regions of the mitochondrial genome, suggesting that some mutations may be non-neutral within specific phylogenetic lineages but neutral in others [35]. Haplogroup cluster HV has been shown to be most non-neutral of the European haplogroup clusters by virtue of the high number of segregating sites and singleton mutations [35]. The pathogenic potential of a mutation may depend on the presence of interacting mutations or on the presence of a certain haplogroup. It is intriguing that nonagenarians have been reported to have lower frequencies of haplogroup H and HV cluster [16] thus supporting that haplogroup H may have a role in neurodegenerative diseases and early aging.
###end p 36
###begin p 37
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 404 412 <span type="species:ncbi:9606">patients</span>
The frequencies of the mtDNA haplogroups vary between populations and even regionally within the same country [36,37]. There are also major differences in haplogroup frequencies between northern and southern Finland [16,25], which implies that it is essential to compare the patients' data with control findings from the same area in order to obtain reliable results. Therefore, we were careful to enrol patients and controls from the same province. Furthermore, the mothers of the controls were required to have been born in the same province as the controls themselves, to ensure that they represented the ancestral population of the province. The average migration rate in the region was low during the period when the mothers of the controls must have been born [25].
###end p 37
###begin p 38
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POLG1 </italic>
###xml 719 724 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
There is considerable evidence of abnormal mitochondrial function and oxidative stress in AD [38,39], where impaired energy metabolism and oxidative damage may precede beta-amyloid deposition [40]. On the other hand, the level of somatic mutations is no higher in AD patients than in aged-matched controls, although mtDNA mutations do increase with age [41]. Oxidative stress and associations with mtDNA have been less intensively studied in the case of FTLD. In this investigation into the role of mtDNA and its maintenance enzymes in Finnish early-onset AD and FTLD patients the two common mtDNA mutations (m.3243A>G, m.8344A>G) and five POLG1 mutations were not found, nor were there any pathogenic mutations in the PEO1 or ANT1 genes. However, we cannot exclude other mitochondrial mutations as the whole mitochondrial genome was not screened.
###end p 38
###begin title 39
Conclusions
###end title 39
###begin p 40
Our analysis revealed a significant association between mtDNA haplogroup cluster IWX and FTLD, suggesting that possession of this cluster may have a role in developing neurodegeneration in FTLD. Further studies in other ethnically distinct cohorts are needed to clarify the contribution of mtDNA haplogroups to FTLD and AD.
###end p 40
###begin title 41
Abbreviations
###end title 41
###begin p 42
AD: Alzheimer's disease; ApoE: apolipoprotein E; ANT1: adenine nucleotide translocator; CSGE: conformation-sensitive gel electrophoresis; eoAD: early-onset Alzheimer's disease; FTLD: frontotemporal lobar degeneration; mtDNA: mitochondrial DNA; POLG1: DNA polymerase gamma; PEO1: progressive external ophthalmoplegia 1.
###end p 42
###begin title 43
Competing interests
###end title 43
###begin p 44
The authors declare that they have no competing interests.
###end p 44
###begin title 45
Authors' contributions
###end title 45
###begin p 46
JK participated in the design of the study, carried out the molecular genetic studies, performed the statistical analysis and drafted the manuscript. RH participated in the design of the study and participated in critical revising of the manuscript. KM participated in the design of the study and participated in critical revising of the manuscript. AMR conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 46
###begin title 47
Supplementary Material
###end title 47
###begin title 48
Additional file 1
###end title 48
###begin p 49
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1</bold>
###xml 4 51 4 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphisms among the eoAD and FTLD patients.</bold>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1 </italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
ANT1polymorphisms among the eoAD and FTLD patients. Table showing ANT1 polymorphisms detected in our cohort of the eoAD and FTLD patients Format: PDF. Size: 9.34 KB. This file can be viewed with: Adobe Acrobat Reader.
###end p 49
###begin p 50
Click here for file
###end p 50
###begin title 51
Additional file 2
###end title 51
###begin p 52
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1</bold>
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>PEO1</bold></italic>
###xml 4 51 4 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphisms among the eoAD and FTLD patients.</bold>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEO1 </italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
PEO1polymorphisms among the eoAD and FTLD patients. Table showing PEO1 polymorphisms detected in our cohort of the eoAD and FTLD patients. Format: PDF. Size: 8.18 KB. This file can be viewed with: Adobe Acrobat Reader.
###end p 52
###begin p 53
Click here for file
###end p 53
###begin title 54
Additional file 3
###end title 54
###begin p 55
###xml 0 126 0 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Frequencies of mtDNA haplogroups among AD patients and controls and relative risk values calculated for the mtDNA haplogroups.</bold>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
Frequencies of mtDNA haplogroups among AD patients and controls and relative risk values calculated for the mtDNA haplogroups. Table showing comparison of the present data with previously published findings on the frequencies of mtDNA haplogroups among AD patients and controls, and relative risk (RR) values for the mtDNA haplogroups among patients with AD. Format: PDF. Size: 26.1 KB. This file can be viewed with: Adobe Acrobat Reader.
###end p 55
###begin p 56
Click here for file
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
###xml 112 120 <span type="species:ncbi:9606">patients</span>
We thank Ms Anja Heikkinen and Ms Pirjo Keranen for their excellent technical assistance. We also thank all the patients and their families for their cooperation. This work was supported financially by grants from the Finnish Alzheimer Foundation for Research, the Orion-Farmos Research Foundation, the Finnish Medical Foundation and the Paivikki and Sakari Sohlberg Foundation and by clinical EVO grants from Oulu University Hospital.
###end p 58
###begin article-title 59
Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum
###end article-title 59
###begin article-title 60
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
###end article-title 60
###begin article-title 61
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration
###end article-title 61
###begin article-title 62
Tau gene mutations and their effects
###end article-title 62
###begin article-title 63
Progranulin null mutations in both sporadic and familial frontotemporal dementia
###end article-title 63
###begin article-title 64
Mitochondria take center stage in aging and neurodegeneration
###end article-title 64
###begin article-title 65
Disorders of nuclear-mitochondrial intergenomic signaling
###end article-title 65
###begin article-title 66
Inherited mitochondrial diseases of DNA replication
###end article-title 66
###begin article-title 67
Alzheimer pathology associated with POLG1 mutation, multiple mtDNA deletions, and APOE4/4: Premature ageing or just coincidence?
###end article-title 67
###begin article-title 68
Mitochondrial disorders, cognitive impairment and dementia
###end article-title 68
###begin article-title 69
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease
###end article-title 69
###begin article-title 70
Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia
###end article-title 70
###begin article-title 71
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease
###end article-title 71
###begin article-title 72
Mitochondrial genotype associated with longevity
###end article-title 72
###begin article-title 73
###xml 91 97 <span type="species:ncbi:9606">humans</span>
Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans
###end article-title 73
###begin article-title 74
Mitochondrial DNA polymorphisms associated with longevity in a Finnish population
###end article-title 74
###begin article-title 75
Analysis of European mitochondrial haplogroups with Alzheimer disease risk
###end article-title 75
###begin article-title 76
Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease
###end article-title 76
###begin article-title 77
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies
###end article-title 77
###begin article-title 78
Does the mitochondrial genome play a role in the etiology of Alzheimer's disease?
###end article-title 78
###begin article-title 79
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany
###end article-title 79
###begin article-title 80
No evidence of association between frontotemporal dementia and major European mtDNA haplogroups
###end article-title 80
###begin article-title 81
###xml 128 133 <span type="species:ncbi:9606">Human</span>
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
###end article-title 81
###begin article-title 82
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
###end article-title 82
###begin article-title 83
Evidence for mtDNA admixture between the Finns and the Saami
###end article-title 83
###begin article-title 84
Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis
###end article-title 84
###begin article-title 85
Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population
###end article-title 85
###begin article-title 86
Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF)
###end article-title 86
###begin article-title 87
Classification of European mtDNAs from an analysis of three European populations
###end article-title 87
###begin article-title 88
Phylogenetic network for European mtDNA
###end article-title 88
###begin article-title 89
Apolipoprotein E genotyping by one-stage PCR
###end article-title 89
###begin article-title 90
Testing heterozygote excess and deficiency
###end article-title 90
###begin article-title 91
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Mitochondrial D-loop variation in Leber hereditary neuropathy patients harboring primary G11778A, G3460A, T14484C mutations: J and W haplogroups as high-risk factors
###end article-title 91
###begin article-title 92
Mitochondrial haplogroup H and Alzheimer's disease-is there a connection?
###end article-title 92
###begin article-title 93
###xml 30 35 <span type="species:ncbi:9606">human</span>
Lineage-specific selection in human mtDNA: Lack of polymorphisms in a segment of MTND5 gene in haplogroup J
###end article-title 93
###begin article-title 94
Saami and Berbers--an unexpected mitochondrial DNA link
###end article-title 94
###begin article-title 95
Geographic patterns of mtDNA diversity in Europe
###end article-title 95
###begin article-title 96
Mitochondrial abnormalities in Alzheimer's disease
###end article-title 96
###begin article-title 97
###xml 86 94 <span type="species:ncbi:9031">chickens</span>
Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: The chickens or the eggs?
###end article-title 97
###begin article-title 98
Oxidative damage is the earliest event in Alzheimer disease
###end article-title 98
###begin article-title 99
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain
###end article-title 99

